Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Lucas R. Massoth, MD, Yin P. Hung, MD, PhD, Judith A. Ferry, MD, Robert P. Hasserjian, MD, Abner Louissaint, Jr., MD PhD, Meagan Montesion, PhD, Ethan S. Sokol, PhD, Dean C. Pavlick, Nikunj Shah, Natalie Danziger, Jonathan Keith Killian, MD,PhD, Eric A. Severson, MD, PhD, MMSc, Daniel Duncan, MD, Julia A. Elvin, MD, PhD, Vincent A. Miller, MD, Jeffrey S. Ross, MD, Jo-Anne Vergilio, MD, Lawrence R. Zukerberg, MD, Erik A. Williams, MD

Blood (2019) 134 (Supplement_1): 2541.

https://doi.org/10.1182/blood-2019-123729

Published: 2019

Journal Articles

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

John G. Quigley, MD, Basharath Khan, MD, Nandini Kalakota, MD, Nathan Aardsma, DO, Nadim Mahmud, MBBS, PhD

Blood (2017) 130 (Supplement 1): 5259.

https://doi.org/10.1182/blood.V130.Suppl_1.5259.5259

Published: 2017

Journal Articles

Bypassing Agents in Children with Inhibitors: How Much Do We Use and How Much Is Too Much?

Deana Gordon, Michael Wang, MD, Katherine Ruegg, BS, Elizabeth Villalobos-Menuey, MS, Marilyn J. Manco-Johnson, MD

Blood (2011) 118 (21): 1217.

https://doi.org/10.1182/blood.V118.21.1217.1217

Published: 2011

Journal Articles

Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All- Trans Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia

Pau Montesinos, MD, Edo Vellenga, Aleksandra Holowiecka, Chelo Rayon, Gustavo Milone, Javier de la Serna, Angel Leon, Juan Bergua, Concha Rivas, Jose Gonzalez, Jordi Esteve, Miguel A. Sanz, MD, PhD, On behalf of the PETHEMA, HOVON, PALG, and GATLA cooperative groups

Blood (2008) 112 (11): 2992.

https://doi.org/10.1182/blood.V112.11.2992.2992

Published: 2008

Journal Articles

BDDrFVIII [moroctocog alfa (AF-CC), Xyntha] for Surgical Hemostasis in Patients with Hemophilia A: Results from a Pivotal Study.

Jerzy Windyga, MD, PhD, Luminita Rusen, MD, PhD, Amanda C. O’Brien, Brooke Hayward, SM, Steven Arkin, MD, David A. Roth, MD

Blood (2008) 112 (11): 1229.

https://doi.org/10.1182/blood.V112.11.1229.1229

Published: 2008

Journal Articles

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

Andrea Gerhardt, MD, Fatima Araba, MD, Rainer B. Zotz, MD, Rudiger E. Scharf, MD

Blood (2006) 108 (11): 4050.

https://doi.org/10.1182/blood.V108.11.4050.4050

Published: 2006

Journal Articles

Role of Radiotherapy in Hemophiliac Pseudotumors: An Experience from India.

Manoranjan Mahapatra, MD, Rajat Kumar, FRCP, Pravas P. Mishra, MD, Renu Saxena, MD, Hara P. Pati, MD, Ved Prakash Choudhry, MD

Blood (2005) 106 (11): 3221.

https://doi.org/10.1182/blood.V106.11.3221.3221

Published: 2005

NARROW

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

Bypassing Agents in Children with Inhibitors: How Much Do We Use and How Much Is Too Much?

Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All- Trans Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia

BDDrFVIII [moroctocog alfa (AF-CC), Xyntha] for Surgical Hemostasis in Patients with Hemophilia A: Results from a Pivotal Study.

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

Role of Radiotherapy in Hemophiliac Pseudotumors: An Experience from India.

Email alerts

ASH Publications

American Society of Hematology

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

Bypassing Agents in Children with Inhibitors: How Much Do We Use and How Much Is Too Much?

Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All- Trans Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia

BDDrFVIII [moroctocog alfa (AF-CC), Xyntha] for Surgical Hemostasis in Patients with Hemophilia A: Results from a Pivotal Study.

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

Role of Radiotherapy in Hemophiliac Pseudotumors: An Experience from India.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only